Cartesian Therapeutics Company
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Technology:
CAR-T
Industry:
Genomic and Epigenominc Instabillity, Private
Headquarters:
Gaithersburg, Maryland, United States
Founded Date:
2016-01-01
Employees Number:
11-50
Investors Number:
2
Total Funding:
2000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-05-04
Last Funding Type:
Grant
Register and Claim Ownership